Literature DB >> 30353360

[Adrenal incidentaloma : Diagnostic and therapeutic concept from an endocrinological perspective].

N Unger1.   

Abstract

An adrenal incidentaloma is an adrenal mass detected on imaging that was not performed for suspected adrenal disease. The prevalence is approximately 3% and increases up to 10% in older people. The risk of malignancy and a hormone excess have to be evaluated. Approximately 15% of incidentalomas harbor an overproduction of hormones, in particular primary aldosteronism (Conn's syndrome), hypercortisolism (Cushing's syndrome) and pheochromocytoma. Primary aldosteronism is the main cause of endocrine hypertension. It is characterized by an overproduction of aldosterone usually due to a unilateral adenoma or an idiopathic, often bilateral hyperplasia. The aldosterone to renin ratio is an established screening parameter for the diagnosis. If the ratio is elevated a confirmatory test, e. g. saline infusion test, should follow. Usually an adrenal venous catheter has to be used to discriminate between unilateral and bilateral aldosterone overproduction. In the case of unilateral overproduction an adrenalectomy is recommended, otherwise treatment is carried out with an aldosterone antagonist. For the diagnosis of an adrenal Cushing's syndromedexamethasone suppression test and a suppressed or in the lower limit of normal ACTH is required. The rare pheochromocytoma is a catecholamine-producing tumor. The diagnosis is carried out by determination of metanephrines in plasma or in 24 h urine samples. Unilateral adrenal tumors leading to clinically significant hormone excess or tumors with suspicion of malignancy should be surgically removed. A minimally invasive adrenalectomy is normally the method of choice in patients with a unilateral adrenal tumor <6 cm and without local tumor invasion. In unilateral, clearly benign, non-functioning, small adrenal tumors (<4 cm) surgery is not required.

Entities:  

Keywords:  Conn’s syndrome; Cushing’s syndrome; Hormone activity; Indications for surgery; Pheochromocytoma

Mesh:

Year:  2019        PMID: 30353360     DOI: 10.1007/s00104-018-0739-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  20 in total

1.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

2.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

Review 3.  Clinical review: Diagnosis and treatment of subclinical hypercortisolism.

Authors:  Iacopo Chiodini
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

4.  Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

Authors:  Iacopo Chiodini; Valentina Morelli; Antonio Stefano Salcuni; Cristina Eller-Vainicher; Massimo Torlontano; Francesca Coletti; Laura Iorio; Antonello Cuttitta; Angelo Ambrosio; Leonardo Vicentini; Fabio Pellegrini; Massimiliano Copetti; Paolo Beck-Peccoz; Maura Arosio; Bruno Ambrosi; Vincenzo Trischitta; Alfredo Scillitani
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

Review 5.  An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges.

Authors:  William M Manger
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

Review 6.  Approach to the patient with an adrenal incidentaloma.

Authors:  Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

7.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

8.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

Review 9.  Subclinical Cushing's syndrome.

Authors:  Monica De Leo; Alessia Cozzolino; Annamaria Colao; Rosario Pivonello
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

10.  Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study.

Authors:  Antonio Toniato; Isabella Merante-Boschin; Giuseppe Opocher; Maria R Pelizzo; Francesca Schiavi; Enzo Ballotta
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

View more
  1 in total

1.  Concomitant Existence of Bilateral Adrenal Adenomas. To Operate or Not?

Authors:  Christos Damaskos; Nikolaos Garmpis; Dimitrios Dimitroulis; Anna Garmpi; Paraskevi Farmaki; Alexandros Patsouras; Vasilili Epameinondas Georgakopoulou; Georgios Kyriakos; Lourdes Victoria Quiles-Sanchez; Athanasios Syllaios; Aliki Liakea; Evangelos Diamantis
Journal:  Maedica (Bucur)       Date:  2021-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.